Moloney Securities Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-907	Closed	-$220K	–	486
2024 Q2	$220K	Sell	907 -1,482	-62%	-$360K	0.03%	406
2024 Q1	$357K	Buy	+2,389	New	+$357K	0.05%	316